The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Vasilyeva L.I.

Dnipropetrovsk Medical Academy, Ministry of Health of Ukraine, Dnipro, Ukraine

Egudina E.D.

Dnipropetrovsk Medical Academy, Ministry of Health of Ukraine, Dnipro, Ukraine

Kalashnikova O.S.

Dnipropetrovsk Medical Academy, Ministry of Health of Ukraine, Dnipro, Ukraine

Zhivilo I.A.

Academician M.D. Strazhesko National Research Center 'Institute of Cardiology', Kiev, Ukraine

Sapozhnichenko L.V.

Dnipropetrovsk Medical Academy, Ministry of Health of Ukraine, Dnipro, Ukraine

Physical rehabilitation of patients with pulmonary hypertension

Authors:

Vasilyeva L.I., Egudina E.D., Kalashnikova O.S., Zhivilo I.A., Sapozhnichenko L.V.

More about the authors

Read: 19621 times


To cite this article:

Vasilyeva LI, Egudina ED, Kalashnikova OS, Zhivilo IA, Sapozhnichenko LV. Physical rehabilitation of patients with pulmonary hypertension. Problems of Balneology, Physiotherapy and Exercise Therapy. 2019;96(5):51‑60. (In Russ.)
https://doi.org/10.17116/kurort20199605151

Recommended articles:
High-flow nasal cannula therapy in patients with COPD. Journal of Respiratory Medi­cine. 2025;(2):17-38

References:

  1. Galiè N, Humbert M, Vachiery J-L, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M; ESC Scientific Document Group. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;(1):67-119. https://doi.org/10.1093/eurheartj/ehv317
  2. Simonneau G. PH haemodynamic definitions and clinical classifications and characteristics of specific PAH subgroups. Materials of 6 World Symposium on Pulmonary Hypertension. Nice. 2018;9.
  3. Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery J.L, Barbera JA,, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G; ESC Committee for Practice Guidelines (CPG). Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J. 2009;30(20):2493-2537. https://doi.org/10.1093/eurheartj/ehp297
  4. Grünig E, Ehlken N, Ghofrani A, Staehler G, Meyer FJ, Juenger J, Opitz CF, Klose H, Wilkens H, Rosenkranz S, Olschewski H, Halank M. Effect of exercise and respiratory training on clinical progression and survival in patients with severe chronic pulmonary hypertension. Respiration. 2011;81(5):394-401. https://doi.org/10.1159/000322475
  5. Sun XG, Hansen JE, Oudiz RJ, Wasserman K. Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation. 2001;104(4):429—435.
  6. Groepenhoff H, Westerhof N, Jacobs W, Boonstra A, Postmus PE, Vonk-Noordegraaf A. Exercise stroke volume and heart rate response differ in right and left heart failure. Eur J Heart Fail. 2010;12(7):716-720. https://doi.org/10.1093/eurjhf/hfq062
  7. Weatherald J, Farina S, Bruno N, Laveneziana P. Cardiopulmonary exercise testing in pulmonary hypertension. Ann Am Thorac Soc. 2017;14(suppl 1):84-92. https://doi.org/10.1513/AnnalsATS.201610-788FR
  8. Triposkiadis F, Karayannis G, Giamouzis G, Skoularigis J, Louridas G, Butler J. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. J Am Coll Cardiol. 2009;54(19):1747-1762. https://doi.org/10.1016/j.jacc.2009.05.015
  9. Pinna GD, Porta A, Maestri R, De Maria B, Dalla Vecchia LA, La Rovere MT. Different estimation methods of spontaneous baroreflex sensitivity have different predictive value in heart failure patients. J Hypertens. 2017;35(8):1666-1675. https://doi.org/10.1097/HJH.0000000000001377
  10. Lador F, Bringard A, Bengueddache S, Ferretti G, Bendjelid K, Soccal PM, Noble S, Beghetti M, Chemla D, Hervé P, Sitbon O. Kinetics of cardiac output at the onset of exercise in precapillary pulmonary hypertension. Biomed Res Int. 2016;2016:6050193.
  11. Waxman AB. Exercise physiology and pulmonary arterial hypertension. Prog Cardiovasc Dis. 2012;55(2):172-179. https://doi.org/10.1016/j.pcad.2012.07.003
  12. Pedersen BK, Febbraio MA. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol. 2012;8(8):457-465. https://doi.org/10.1038/nrendo.2012.49
  13. Franssen FM, Wouters EF, Schols AM. The contribution of starvation, deconditioning and ageing to the observed alterations in peripheral skeletal muscle in chronic organ diseases. Clin Nutr. 2002;21(1):1-14. https://doi.org/10.1054/clnu.2001.0485
  14. Potus F, Malenfant S, Graydon C, Mainguy V, Tremblay È, Breuils-Bonnet S, Ribeiro F, Porlier A, Maltais F, Bonnet S, Provencher S. Impaired angiogenesis and peripheral muscle microcirculation loss contribute to exercise intolerance in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2014;190(3):318-328. https://doi.org/10.1164/rccm.201402-0383OC
  15. Reid MB, Lannergren J, Westerblad H. Respiratory and limb muscle weakness induced by tumor necrosis factor-alpha: involvement of muscle myofilaments. Am J Respir Crit Care Med. 2002;166(4):479-484.
  16. Li YP, Chen Y, John J, Moylan J, Jin B, Mann DL, Reid MB. TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle. FASEB J. 2005;19(3):362-370. https://doi.org/10.1096/fj.04-2364com
  17. Barbosa PB, Ferreira EM, Arakaki JS, Takara LS, Moura J, Nascimento RB, Nery LE, Neder JA. Kinetics of skeletal muscle O2 delivery and utilization at the onset of heavy-intensity exercise in pulmonary arterial hypertension. Eur J Appl Physiol. 2011;111(8):1851-1861. https://doi.org/10.1007/s00421-010-1799-6
  18. Mainguy V, Maltais F, Saey D, Gagnon P, Martel S, Simon M, Provencher S. Peripheral muscle dysfunction in idiopathic pulmonary arterial hypertension. Thorax. 2010;65(2):113-117. https://doi.org/10.1136/thx.2009.117168
  19. Naeije R, Chesler N. Pulmonary circulation at exercise. Compr Physiol. 2012;2(1):711-741.
  20. Marra AM, Arcopinto M, Bossone E, Ehlken N, Cittadini A, Grünig E4. Pulmonary arterial hypertension-related myopathy: an overview of current data and future perspectives. Nutr Metab Cardiovasc Dis. 2015;25(2):131-139. https://doi.org/10.1016/j.numecd.2014.10.005
  21. Moreira-Gonçalves D, Ferreira R, Fonseca H, Padrão AI, Moreno N, Silva AF, Vasques-Nóvoa F, Gonçalves N, Vieira S, Santos M, Amado F, Duarte JA, Leite-Moreira AF, Henriques-Coelho T. Cardioprotective effects of early and late aerobic exercise training in experimental pulmonary arterial hypertension. Basic Res Cardiol. 2015;110(6):57. https://doi.org/10.1007/s00395-015-0514-5
  22. Pacagnelli FL, De Almeida Sabela AK, Okoshi K, Mariano TB, Campos DH, Carvalho RF, Cicogna AC, Vanderlei LC. Preventive aerobic training exerts a cardioprotective effect on rats treated with monocrotaline. Int J Exp Pathol. 2016;97(3):238-247. https://doi.org/10.1111/iep.12166
  23. Spruijt OA, de Man FS, Groepenhoff H, Oosterveer F, Westerhof N, Vonk-Noordegraaf A, Bogaard HJ. The effects of exercise on right ventricular contractility and right ventricular-arterial coupling in pulmonary hypertension. Am J Respir Crit Care Med. 2015;191(9):1050-1057. https://doi.org/10.1164/rccm.201412-2271OC
  24. Handoko ML, De Man FS, Happé CM, Schalij I, Musters RJ, Westerhof N, Postmus PE, Paulus WJ, van der Laarse WJ, Vonk-Noordegraaf A. Opposite effects of training in rats with stable and progressive pulmonary hypertension. Circulation. 2009;120(1):42-49. https://doi.org/10.1161/CIRCULATIONAHA.108.829713
  25. Balady GJ, Arena R, Sietsema K, Myers J, Coke L, Fletcher GF, Forman D, Franklin B, Guazzi M, Gulati M, Keteyian SJ, Lavie CJ, Macko R, Mancini D, Milani RV; American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee of the Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council on Peripheral Vascular Disease; Interdisciplinary Council on Quality of Care and Outcomes Research. Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults: A Scientific Statement From the American Heart Association. Circulation. 2010;122(2):191-225. https://doi.org/10.1161/CIR.0b013e3181e52e69
  26. Arena R, Myers J, Guazzi M. Cardiopulmonary exercise testing is a core assessment for patients with heart failure. Congest Heart Fail. 2011;17(3):115-119. https://doi.org/10.1111/j.1751-7133.2011.00216.x
  27. Kudryashev VE, Ivanov SV, Beleckii YuV. Kolichestvennaya otsenka narushenii krovoobrashcheniya (proby s fizicheskoi nagruzkoi. M.: Medicina; 2000. (In Russ.)
  28. Herdy AH, López-Jimenez F, Terzic CP, Milani M, Stein R, Carvalho T, Serra S, Araujo CG, Zeballos PC, Anchique CV, Burdiat G, González K, González G, Fernández R, Santibáñez C, Rodríguez-Escudero JP, Ilarraza-Lomelí H. South American guidelines for cardiovascular disease prevention and rehabilitation. Arq Bras Cardiol. 2014;103(2 suppl 1):1-31.
  29. Cahalin LP, Chase P, Arena R, Myers J, Bensimhon D, Peberdy MA, Ashley E, West E, Forman DE, Pinkstaff S, Lavie CJ, Guazzi M. A meta-analysis of the prognostic significance of cardiopulmonary exercise testing in patients with heart failure. Heart Fail Rev. 2013;18(1):79-94. https://doi.org/10.1007/s10741-012-9332-0
  30. Guazzi M, Adams V, Conraads V, Halle M, Mezzani A, Vanhees L, Arena R, Fletcher GF, Forman DE, Kitzman DW, Lavie CJ, Myers J; European Association for Cardiovascular Prevention & Rehabilitation; American Heart Association. EACPR/AHA Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Circulation. 2012;126(18):2261-2274. https://doi.org/10.1161/CIR.0b013e31826fb946
  31. Herdy AH, Uhnlerdorf D. Reference values for cardiopulmonary exercise testing for sedentary and active men and women. Arq Bras Cardiol. 2011;96(1):54-59.
  32. Sorajja P, Allison T, Hayes C, Nishimura RA, Lam CS, Ommen SR. Prognostic utility of metabolic exercise testing in minimally symptomatic patients with obstructive hypertrophic cardiomyopathy. Am J Cardiol. 2012;109(10):1494-1498. https://doi.org/10.1016/j.amjcard.2012.01.363
  33. Guazzi M, Adams V, Conraads V, Halle M, Mezzani A, Vanhees L, Arena R, Fletcher GF, Forman DE, Kitzman DW, Lavie CJ, Myers J; EACPR; AHA. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Eur Heart J. 2012;33(23):2917-2927. https://doi.org/10.1093/eurheartj/ehs221
  34. Vonk MC, Sander MH, van den Hoogen FH, van Riel PL, Verheugt FW, van Dijk AP. Right ventricle Tei-index: A tool to increase the accuracy of non-invasive detection of pulmonary arterial hypertension in connective tissue diseases. Eur J Echocardiogr. 2007;8(5):317-321.
  35. Bossone E, Rubenfire M, Bach DS, Ricciardi M, Armstrong WF. Range of tricuspid regurgitation velocity at rest and during exercise in normal adult men: implications for the diagnosis of pulmonary hypertension. J Am Coll Cardiol. 1999;33(6):1662-1666.
  36. Farina S, Teruzzi G, Cattadori G, Ferrari C, De Martini S, Bussotti M, Calligaris G, Bartorelli A, Agostoni P. Noninvasive cardiac output measurement by inert gas rebreathing in suspected pulmonary hypertension. Am J Cardiol. 2014;113(3):546-551. https://doi.org/10.1016/j.amjcard.2013.10.017
  37. Grünig E, Tiede H, Enyimayew EO, Ehlken N, Seyfarth HJ, Bossone E, D’Andrea A, Naeije R, Olschewski H, Ulrich S, Nagel C, Halank M, Fischer C. Assessment and prognostic relevance of right ventricular contractile reserve in patients with severe pulmonary hypertension. Circulation. 2013;128(18):2005-2015. https://doi.org/10.1161/CIRCULATIONAHA.113.001573
  38. La Gerche A, Claessen G, Van de Bruaene A, Pattyn N, Van Cleemput J, Gewillig M, Bogaert J, Dymarkowski S, Claus P, Heidbuchel H. Cardiac MRI: a new gold standard for ventricular volume quantification during high-intensity exercise. Circ Cardiovasc Imaging. 2013;6(2):329-338. https://doi.org/10.1161/CIRCIMAGING.112.980037
  39. Mereles D, Ehlken N, Kreuscher S, Ghofrani S, Hoeper MM, Halank M, Meyer FJ, Karger G, Buss J, Juenger J, Holzapfel N, Opitz C, Winkler J, Herth FF, Wilkens H, Katus HA, Olschewski H, Grünig E. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation. 2006;114(14):1482-1489.
  40. Ries AL, Bauldoff GS, Carlin BW. Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest. 2007;131(5 suppl):4-42.
  41. de Man FS, Handoko ML, Groepenhoff H. Effects of exercise training in patients with idiopathic pulmonary arterial hypertension. Eur Respir J. 2009;34(3):669-675. https://doi.org/10.1183/09031936.00027909
  42. Pollock ML, Franklin BA, Balady GJ. AHA Science Advisory. Resistance exercise in individuals with and without cardiovascular disease: benefits, rationale, safety, and prescription: An advisory from the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiology, American Heart Association; Position paper endorsed by the American College of Sports Medicine. Circulation. 2000;101(7):828-833.
  43. Mainguy V, Maltais F, Saey D. Effects of a Rehabilitation Program on Skeletal Muscle Function in Idiopathic Pulmonary Arterial Hypertension. J Cardiopulm Rehabil Prev. 2010. https://doi.org/10.1097/HCR.0b013e3181d6f962
  44. Pandey A, Garg S, Khunger M, Garg S, Kumbhani DJ, Chin KM, Berry JD. Efficacy and Safety of Exercise Training in Chronic Pulmonary Hyper- tension: Systematic Review and Meta-Analysis. Circ Heart Fail. 2015;8(6):1032-1043. PubMed. https://doi.org/10.21275/v4i11.NOV151297
  45. Verma S, Cardenas-Garcia J, Mohapatra PR, Talwar A. Depression in pulmonary arterial hypertension and interstitial lung diseases. N Am J Med Sci. 2014;6(6):240-249.
  46. Talwar A, Sahni S, John S, Verma S, Cárdenas-Garcia J, Kohn N. Effects of pulmonary rehabilitation on Fatigue Severity Scale in patients with lung disease. Pneumonol Alergol Pol. 2014;82(6):534-540. https://doi.org/10.5603/PiAP.2014.0070
  47. Taichman DB, Shin J, Hud L, Archer-Chicko C, Kaplan S, Sager JS, Gallop R, Christie J, Hansen-Flaschen J, Palevsky H. Health-related quality of life in patients with pulmonary arterial hypertension. Respir Res. 2005;6:92. https://doi.org/10.1186/1465-9921-6-92
  48. Kim EJ, Verma S, Sahni S, et al. Dyspnea, depression and health related quality of life [HRQoL] in pa- tients with pulmonary arterial hypertension [PAH]. Chest. 2013;144(4 Meeting Abstracts):864A-A.
  49. Chan L, Chin LM, Kennedy M, Woolstenhulme JG, Nathan SD, Weinstein AA, Connors G, Weir NA, Drinkard B, Lamberti J, Keyser RE. Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension. Chest. 2013;143(2):333-343. https://doi.org/10.1378/chest.12-0993
  50. Nagel C, Prange F, Guth S, Herb J, Ehlken N, Fischer C, Reichenberger F, Rosenkranz S, Seyfarth HJ, Mayer E, Halank M, Grünig E. Exercise training improves exercise capacity and quality of life in patients with inoperable or residual chronic thromboembolic pulmonary hypertension. PLoS One. 2012;7(7):e41603. https://doi.org/10.1371/journal.pone.0041603
  51. Becker-Grünig E, Maier F, Ehlken N, Fischer C, Lichtblau M, Blank N, Fiehn C, Stöckl F, Prange F, Staehler G, Reichenberger F, Tiede H, Halank M, Seyfarth HJ, Wagner S, Nagel C. Exercise training in pulmonary arterial hypertension associated with connective tissue diseases. Arthritis Res Ther. 2012;14(3):148. https://doi.org/10.1186/ar3883
  52. Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, Hill K, Holland AE, Lareau SC, Man WD, Pitta F, Sewell L, Raskin J, Bourbeau J, Crouch R, Franssen FM, Casaburi R, Vercoulen JH, Vogiatzis I, Gosselink R, Clini EM, Effing TW, Maltais F, van der Palen J, Troosters T, Janssen DJ, Collins E, Garcia-Aymerich J, Brooks D, Fahy BF, Puhan MA, Hoogendoorn M, Garrod R, Schols AM, Carlin B, Benzo R, Meek P, Morgan M, Rutten-van Mölken MP, Ries AL, Make B, Goldstein RS, Dowson CA, Brozek JL, Donner CF, Wouters EF; ATS/ERS Task Force on Pulmonary Rehabilitation. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):13-64. https://doi.org/10.1164/rccm.201309-1634ST
  53. Osadnik CR, Rodrigues FMM, Camillo CA, Loeckx M, Janssens W, Dooms C, Troosters T. Principles of rehabilitation and reactivation. Respiration. 2015;89(1):2-11. https://doi.org/10.1159/000370246
  54. Marra AM, Egenlauf B, Bossone E, Eichstaedt C, Grünig E, Ehlken N. Principles of rehabilitation and reactivation:pulmonary hypertension. Respiration. 2015;89(4):265-273. https://doi.org/10.1159/000371855
  55. Grunig E, Lichtblau M, Ehlken N, Ghofrani HA, Reichenberger F, Staehler G, Halank M, Fischer C, Seyfarth HJ, Klose H, Meyer A, Sorichter S, Wilkens H, Rosenkranz S, Opitz C, Leuchte H, Karger G, Speich R, Nagel C. Safety and efficacy of exercise training in various forms of pulmonary hypertension. Eur Respir J. 2012;40(1):84-92. https://doi.org/10.1183/09031936.00123711

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.